Reported Consolidated quarterly numbers for Vivimed Labs are:
Net Sales at Rs 37.03 crore in March 2023 down 39.43% from Rs. 61.13 crore in March 2022.
Story continues below Advertisement
Quarterly Net Loss at Rs. 265.99 crore in March 2023 down 1350.82% from Rs. 18.33 crore in March 2022.
EBITDA stands negative at Rs. 163.61 crore in March 2023 down 31980.39% from Rs. 0.51 crore in March 2022.
Vivimed Labs shares closed at 5.75 on May 29, 2023 (NSE) and has given -35.75% returns over the last 6 months and -56.11% over the last 12 months.
Story continues below Advertisement
| Vivimed Labs | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Mar'23 | Dec'22 | Mar'22 | | Net Sales/Income from operations | 37.03 | 55.74 | 61.13 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 37.03 | 55.74 | 61.13 | | EXPENDITURE | | Consumption of Raw Materials | 22.71 | 35.89 | 36.51 | | Purchase of Traded Goods | 0.06 | 0.74 | -- | | Increase/Decrease in Stocks | 159.25 | 1.45 | 1.20 | | Power & Fuel | -- | -- | -- | | Employees Cost | 8.82 | 9.47 | 9.68 | | Depreciation | 95.92 | 4.02 | 4.95 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 10.49 | 13.31 | 14.82 | | P/L Before Other Inc., Int., Excpt. Items & Tax | -260.22 | -9.15 | -6.03 | | Other Income | 0.68 | 0.05 | 0.57 | | P/L Before Int., Excpt. Items & Tax | -259.53 | -9.09 | -5.46 | | Interest | 8.52 | 9.22 | 10.06 | | P/L Before Exceptional Items & Tax | -268.05 | -18.31 | -15.52 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -268.05 | -18.31 | -15.52 | | Tax | -2.07 | -- | 2.82 | | P/L After Tax from Ordinary Activities | -265.99 | -18.31 | -18.33 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -265.99 | -18.31 | -18.33 | | Minority Interest | -- | -- | -- | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | -265.99 | -18.31 | -18.33 | | Equity Share Capital | 16.58 | 16.58 | 16.58 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -32.05 | -0.22 | -2.21 | | Diluted EPS | -31.14 | -0.21 | -2.15 | | EPS After Extra Ordinary | | Basic EPS | -32.05 | -0.22 | -2.21 | | Diluted EPS | -31.14 | -0.21 | -2.15 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
